US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million-pound battle against US rival Moderna over the Covid-19 vaccine. The Appeals ...

Q2 2025 Earnings Call Transcript August 1, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-2.13, ...

HHS Secretary Robert F. Kennedy Jr. has upended the way Covid vaccines are approved and for whom they’re recommended, ...

Exxon Mobil CEO Darren Woods said the oil giant is looking for acquisition opportunities in the oil-and-gas space after losing its challenge to Chevron's $53 billion deal to buy Hess. Wal-Mart de ...

Live Updates Live Coverage Has Ended Friday Wrap-up 4:19 pm The Vanguard S&P 500 ETF closed Friday at 571.45, down 1.6% for ...

Moderna has announced that it plans to cut down 10% of its workforce by the end of the year. CEO Stephane Bancel said in a ...

Even before today's dismal jobs report, companies have been sounding off on layoffs and slower hiring in recent weeks. On Thursday, Moderna executives said the biotech company would [reduce its headco ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

Shares of the biotech fell even as second-quarter loss per share came in at $2.13 on revenue of $142 million, beating ...

Moderna reduced its 2025 revenue forecast due to deferred UK vaccine deliveries. Despite a smaller-than-expected quarterly loss, its shares fell 7%. The company faces challenges from declining ...